| 393.33 9.79 (2.55%) | 09-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 473.43 | 1-year : | 552.97 |
| Resists | First : | 405.33 | Second : | 473.43 |
| Pivot price | 371.62 |
|||
| Supports | First : | 368.2 | Second : | 345.25 |
| MAs | MA(5) : | 382.85 |
MA(20) : | 371.8 |
| MA(100) : | 399.32  |
MA(250) : | 465.24 |
|
| MACD | MACD : | 0.8 |
Signal : | -2.3 |
| %K %D | K(14,3) : | 91.5 |
D(3) : | 88.4 |
| RSI | RSI(14): 61.1 |
|||
| 52-week | High : | 603.88 | Low : | 328.57 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ ISRG ] has closed below upper band by 0.3%. Bollinger Bands are 19.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 395.06 - 396.58 | 396.58 - 398.1 |
| Low: | 375.55 - 377.36 | 377.36 - 379.16 |
| Close: | 390.37 - 393.18 | 393.18 - 395.99 |
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
Sun, 20 Sep 2026
Intuitive Surgical (ISRG) Down 30% This Year; Can Tonight’s Q2 Earnings Reverse the Bearish Channel? - TradingKey
Wed, 16 Sep 2026
Intuitive Surgical (ISRG) exec sells 1,089 shares under trading plan - Stock Titan
Wed, 16 Sep 2026
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - finance.yahoo.com
Tue, 15 Sep 2026
Intuitive Surgical (NASDAQ: ISRG) officer plans 2026 stock sale - Stock Titan
Tue, 15 Sep 2026
What Is Intuitive Surgical (ISRG) Gaining From Its First CE Mark In Gynecology? - finance.yahoo.com
Tue, 15 Sep 2026
Intuitive Surgical Inc (ISRG): GF Score of 93 Signals Strong Out - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 358 (M) |
| Shares Float | 351 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 89.5 (%) |
| Shares Short | 7,070 (K) |
| Shares Short P.Month | 6,710 (K) |
| EPS | 8.72 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 51.34 |
| Profit Margin | 28.4 % |
| Operating Margin | 33.5 % |
| Return on Assets (ttm) | 10.5 % |
| Return on Equity (ttm) | 17.4 % |
| Qtrly Rev. Growth | 18.5 % |
| Gross Profit (p.s.) | 20.54 |
| Sales Per Share | 30.78 |
| EBITDA (p.s.) | 11.66 |
| Qtrly Earnings Growth | 26.5 % |
| Operating Cash Flow | 3,710 (M) |
| Levered Free Cash Flow | 2,620 (M) |
| PE Ratio | 45.05 |
| PEG Ratio | 1.6 |
| Price to Book value | 7.66 |
| Price to Sales | 12.77 |
| Price to Cash Flow | 37.98 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|